<![CDATA[Genmab — April 2020]]>God morgen. 🙂

]]>https://dev.proinvestor.com/forum/topic/451541/genmab-april-2020RSS for NodeSat, 13 Jun 2026 14:54:51 GMTWed, 01 Apr 2020 03:32:36 GMT60<![CDATA[Reply to Genmab — April 2020 on Thu, 30 Apr 2020 18:21:14 GMT]]>Mon det er i morgen at kurserne skal sydpå til en ny langvarig bundvending nøjagtig som godkendelsen tikker ind, timingen har aldrig været specielt heldig for Genmab, nå men falder nok kun 3% i morgen.

]]>https://dev.proinvestor.com/forum/post/10224712https://dev.proinvestor.com/forum/post/10224712Thu, 30 Apr 2020 18:21:14 GMT<![CDATA[Reply to Genmab — April 2020 on Thu, 30 Apr 2020 17:43:26 GMT]]>Måske skal du fryse resten af pighvarren ned... 🙂

]]>https://dev.proinvestor.com/forum/post/10224710https://dev.proinvestor.com/forum/post/10224710Thu, 30 Apr 2020 17:43:26 GMT<![CDATA[Reply to Genmab — April 2020 on Thu, 30 Apr 2020 17:10:08 GMT]]>Godt vi har aktierne. Alt det bagefis er ikke til at holde ud ....

]]>https://dev.proinvestor.com/forum/post/10224709https://dev.proinvestor.com/forum/post/10224709Thu, 30 Apr 2020 17:10:08 GMT<![CDATA[Reply to Genmab — April 2020 on Thu, 30 Apr 2020 17:03:19 GMT]]>Very good it includes all indications.

]]>https://dev.proinvestor.com/forum/post/10224715https://dev.proinvestor.com/forum/post/10224715Thu, 30 Apr 2020 17:03:19 GMT<![CDATA[Reply to Genmab — April 2020 on Thu, 30 Apr 2020 17:01:59 GMT]]>Glad to see that confirmed

]]>https://dev.proinvestor.com/forum/post/10224713https://dev.proinvestor.com/forum/post/10224713Thu, 30 Apr 2020 17:01:59 GMT<![CDATA[Reply to Genmab — April 2020 on Thu, 30 Apr 2020 17:01:56 GMT]]>Jeg købte lidt HALO i forventning til hurtig gevinst 😞

]]>https://dev.proinvestor.com/forum/post/10224708https://dev.proinvestor.com/forum/post/10224708Thu, 30 Apr 2020 17:01:56 GMT<![CDATA[Reply to Genmab — April 2020 on Thu, 30 Apr 2020 17:01:47 GMT]]>The CHMP’s Positive Opinion for the subcutaneous formulation of daratumumab applies to all currently approved daratumumab indications in frontline and relapsed / refractory multiple myeloma settings.

]]>https://dev.proinvestor.com/forum/post/10224704https://dev.proinvestor.com/forum/post/10224704Thu, 30 Apr 2020 17:01:47 GMT<![CDATA[Reply to Genmab — April 2020 on Thu, 30 Apr 2020 16:58:09 GMT]]>Now from Genmab https://ir.genmab.com/news-releases/news-release-details/chmp-issues-positive-opinion-recommending-subcutaneous

]]>https://dev.proinvestor.com/forum/post/10224705https://dev.proinvestor.com/forum/post/10224705Thu, 30 Apr 2020 16:58:09 GMT<![CDATA[Reply to Genmab — April 2020 on Thu, 30 Apr 2020 16:56:43 GMT]]>Kan ikke lige ses på kursen.

]]>https://dev.proinvestor.com/forum/post/10224714https://dev.proinvestor.com/forum/post/10224714Thu, 30 Apr 2020 16:56:43 GMT<![CDATA[Reply to Genmab — April 2020 on Thu, 30 Apr 2020 16:56:27 GMT]]>Mon det smitter af på Halo?

]]>https://dev.proinvestor.com/forum/post/10224703https://dev.proinvestor.com/forum/post/10224703Thu, 30 Apr 2020 16:56:27 GMT<![CDATA[Reply to Genmab — April 2020 on Thu, 30 Apr 2020 16:47:35 GMT]]>Nu ligger førerfeltet jo ret tæt samlet. Så en plads 6-9 er ret sandsynlig.

]]>https://dev.proinvestor.com/forum/post/10224706https://dev.proinvestor.com/forum/post/10224706Thu, 30 Apr 2020 16:47:35 GMT<![CDATA[Reply to Genmab — April 2020 on Thu, 30 Apr 2020 16:44:47 GMT]]>Bare en spøjs statistik

]]>https://dev.proinvestor.com/forum/post/10224699https://dev.proinvestor.com/forum/post/10224699Thu, 30 Apr 2020 16:44:47 GMT<![CDATA[Reply to Genmab — April 2020 on Thu, 30 Apr 2020 16:43:56 GMT]]>9th place ????for Darzalex revenues in 2026 ? https://www.evaluate.com/vantage/articles/data-insights/long-term-forecasts-confirm-keytrudas-dominance

]]>https://dev.proinvestor.com/forum/post/10224711https://dev.proinvestor.com/forum/post/10224711Thu, 30 Apr 2020 16:43:56 GMT<![CDATA[Reply to Genmab — April 2020 on Thu, 30 Apr 2020 16:40:01 GMT]]>Following a CHMP opinion the European Commission takes usually its
decision, a legally binding authorisation, after 67 days.

]]>https://dev.proinvestor.com/forum/post/10224701https://dev.proinvestor.com/forum/post/10224701Thu, 30 Apr 2020 16:40:01 GMT<![CDATA[Reply to Genmab — April 2020 on Thu, 30 Apr 2020 16:38:27 GMT]]>Let the penetration begin

]]>https://dev.proinvestor.com/forum/post/10224707https://dev.proinvestor.com/forum/post/10224707Thu, 30 Apr 2020 16:38:27 GMT<![CDATA[Reply to Genmab — April 2020 on Thu, 30 Apr 2020 16:35:53 GMT]]>YES 🙂

]]>https://dev.proinvestor.com/forum/post/10224700https://dev.proinvestor.com/forum/post/10224700Thu, 30 Apr 2020 16:35:53 GMT<![CDATA[Reply to Genmab — April 2020 on Thu, 30 Apr 2020 16:31:32 GMT]]>https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-28-30-april-2020

]]>https://dev.proinvestor.com/forum/post/10224694https://dev.proinvestor.com/forum/post/10224694Thu, 30 Apr 2020 16:31:32 GMT<![CDATA[Reply to Genmab — April 2020 on Thu, 30 Apr 2020 16:31:03 GMT]]>The CHMP recommended the addition of a new pharmaceutical form (solution for injection) associated with a new strength and a new route of administration (subcutaneous injection into the abdomen) for Darzalex (daratumumab).

]]>https://dev.proinvestor.com/forum/post/10224702https://dev.proinvestor.com/forum/post/10224702Thu, 30 Apr 2020 16:31:03 GMT<![CDATA[Reply to Genmab — April 2020 on Thu, 30 Apr 2020 16:31:00 GMT]]>SC EUROPE

]]>https://dev.proinvestor.com/forum/post/10224696https://dev.proinvestor.com/forum/post/10224696Thu, 30 Apr 2020 16:31:00 GMT<![CDATA[Reply to Genmab — April 2020 on Thu, 30 Apr 2020 16:30:56 GMT]]>YES!

]]>https://dev.proinvestor.com/forum/post/10224698https://dev.proinvestor.com/forum/post/10224698Thu, 30 Apr 2020 16:30:56 GMT<![CDATA[Reply to Genmab — April 2020 on Thu, 30 Apr 2020 16:28:12 GMT]]>😄 JNJ should use that in their marketing lol

]]>https://dev.proinvestor.com/forum/post/10224695https://dev.proinvestor.com/forum/post/10224695Thu, 30 Apr 2020 16:28:12 GMT<![CDATA[Reply to Genmab — April 2020 on Thu, 30 Apr 2020 16:15:02 GMT]]>I like this line. https://ashpublications.org/blood/article-abstract/135/18/1509/454455/AL-patients-don-t-dare-go-without-dara?redirectedFrom=fulltext 🙂

]]>https://dev.proinvestor.com/forum/post/10224697https://dev.proinvestor.com/forum/post/10224697Thu, 30 Apr 2020 16:15:02 GMT<![CDATA[Reply to Genmab — April 2020 on Thu, 30 Apr 2020 15:48:38 GMT]]>Safety, tolerability, and response rates of daratumumab in relapsed AL amyloidosis: results of a phase 2 study https://ashpublications.org/blood/article-abstract/135/18/1541/440750/Safety-tolerability-and-response-rates-of

]]>https://dev.proinvestor.com/forum/post/10224693https://dev.proinvestor.com/forum/post/10224693Thu, 30 Apr 2020 15:48:38 GMT<![CDATA[Reply to Genmab — April 2020 on Thu, 30 Apr 2020 15:45:14 GMT]]>Blood: A prospective phase 2 trial of daratumumab in patients with previously treated systemic light-chain amyloidosis https://ashpublications.org/blood/article-abstract/135/18/1531/452572/A-prospective-phase-2-trial-of-daratumumab-in

]]>https://dev.proinvestor.com/forum/post/10224690https://dev.proinvestor.com/forum/post/10224690Thu, 30 Apr 2020 15:45:14 GMT